Your browser doesn't support javascript.
loading
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
He, Jing; Zhang, Xia; Wei, Yunbo; Sun, Xiaolin; Chen, Yaping; Deng, Jun; Jin, Yuebo; Gan, Yuzhou; Hu, Xin; Jia, Rulin; Xu, Chuanhui; Hou, Zhaohua; Leong, Yew Ann; Zhu, Lei; Feng, Jinhong; An, Yuan; Jia, Yuan; Li, Chun; Liu, Xu; Ye, Hua; Ren, Limin; Li, Ru; Yao, Haihong; Li, Yuhui; Chen, Shi; Zhang, Xuewu; Su, Yin; Guo, Jianping; Shen, Nan; Morand, Eric F; Yu, Di; Li, Zhanguo.
Afiliação
  • He J; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Zhang X; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Wei Y; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
  • Sun X; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Chen Y; Laboratory for Molecular Immunomodulation, Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Deng J; China-Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Jin Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Gan Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Hu X; Laboratory for Molecular Immunomodulation, Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Jia R; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Xu C; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Hou Z; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
  • Leong YA; Laboratory for Molecular Immunomodulation, Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
  • Zhu L; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Feng J; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
  • An Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Jia Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Li C; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Liu X; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Ye H; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Ren L; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Li R; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Yao H; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Li Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Chen S; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Zhang X; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Su Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Guo J; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
  • Shen N; China-Australia Centre for Personalised Immunology, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Morand EF; Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Yu D; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Shandong Academy of Sciences, Jinan, China.
  • Li Z; Laboratory for Molecular Immunomodulation, Department of Biochemistry and Molecular Biology, Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Nat Med ; 22(9): 991-3, 2016 09.
Article em En | MEDLINE | ID: mdl-27500725
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Linfócitos T Reguladores / Linfócitos T Auxiliares-Indutores / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-2 / Linfócitos T Reguladores / Linfócitos T Auxiliares-Indutores / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article